Page last updated: 2024-10-31

mexiletine and Briquet Syndrome

mexiletine has been researched along with Briquet Syndrome in 1 studies

Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.

Research Excerpts

ExcerptRelevanceReference
"Once erythromelalgia was suspected clinically, the SCN9A gene was sequenced."2.50An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder. ( Meijer, IA; Nizard, S; Robitaille, Y; Rossignol, E; Vanasse, M, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meijer, IA1
Vanasse, M1
Nizard, S1
Robitaille, Y1
Rossignol, E1

Reviews

1 review available for mexiletine and Briquet Syndrome

ArticleYear
An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder.
    Muscle & nerve, 2014, Volume: 49, Issue:1

    Topics: Carbamazepine; Child, Preschool; Comorbidity; Erythromelalgia; Female; Humans; Hypesthesia; Mexileti

2014